<DOC>
	<DOCNO>NCT01405976</DOCNO>
	<brief_summary>Primary objective : evaluate efficacy noninvasive ventilation ( NIV ) treatment versus continuous positive airway pressure ( CPAP ) `` historic '' treatment ( weight loss oxygen ) Obesity Hipoventilation Syndrome ( OHS ) , PCO2 day hospitalization analyze primary variable percentage dropouts medical reason mortality operative variable . As secondary variable : Measure functional clinical improvement sleep wakefulness , quality life , incidence evolution cardiovascular event . Objectives secondary : role apneogenic sleep event molecular inflammation , endothelial damage genesis diurnal hypercapnia . Methods : prospective , randomize control trial . Patients OHS divide initially two group base apnea-hypopnea index ( AHI ) score , &gt; =30 &lt; 30 , use conventional polysomnography . The AHI &gt; =30 group randomize CPAP , NIV historic treatment . The AHI &lt; =30 group randomize NIV historic treatment . Treatment efficacy medium- long-term analyze comparing group . The role apneic event leptin genesis daytime alveolar hypoventilation analyze compare daytime PCO2/AHI coefficient responder non-responders CPAP treatment , evolution leptin level four branch study . The role apneic event metabolic biochemical alteration endothelial dysfunction analyze compare basal post-treatment level relate substance group , without significant AHI .</brief_summary>
	<brief_title>Alternative Treatment Obesity Hypoventilation Syndrome</brief_title>
	<detailed_description>The AHI &gt; =30 group analyze CPAP , NIV historic treatment two mouths.Once evaluation do period , historical medical treatment randomize NIV/CPAP treatment continuation three year .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<criteria>Age 15 80 year old . Absence moderate severe chronic obstructive pulmonary disease ( COPD ) . Absence neuromuscular , chest wall metabolic disease cause daytime hypercapnia . Absence narcolepsy restless legs syndrome Exceed correctly treatment least 30 minute CPAP/NIV wakefulness . Psychophysical incapacity answer questionnaire . Patients able evaluated mean quality life questionnaire suffer restrictive chronic disease previously diagnose ( neoplasy , chronic pain origin , renal failure , severe chronic obstructive pulmonary disease restrictive chronic disease ) . Subjects important chronic nasal obstruction prevents use CPAP/NIV . Informed consent obtain .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>noninvasive ventilation</keyword>
	<keyword>CPAP</keyword>
</DOC>